BackOncternal Therapeutics Overview

Oncternal Therapeutics Current Cash

Oncternal Therapeutics's current cash is $13M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$13.08M
↓ 12.37% YoYΔ $-1.85M vs prior year quarter

Peer trimmed avg / median

Loading

Oncternal Therapeutics Current Cash History

Loading

Oncternal Therapeutics vs. peers: Current Cash Comparison

Loading

Oncternal Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Oncternal Therapeutics (ONCT) FAQ

Oncternal Therapeutics (ONCT) currently reports a current cash of $13M as of September 2024. That compares with $15M in the prior-year period — down 12.4% year over year. Use the charts on this page to explore Oncternal Therapeutics's current cash history and peer comparisons.

Oncternal Therapeutics's current cash decreased from $15M to $13M — a 12.4% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Oncternal Therapeutics reported $13M in current cash as of September 2024. That compares with $15M in the prior-year period — down 12.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Oncternal Therapeutics, and consider following ONCT for alerts when major investors trade the stock.

Oncternal Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ONCT with unrelated industries.